National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
14Maximum amount—chemotherapy drugs
Start here
Get a plain-English read of 14
Turn the raw legal text into a practical explanation grounded in National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
14 Maximum amount—chemotherapy drugs
(1) This section determines the maximum amount of a chemotherapy drug that an authorised prescriber may, in one chemotherapy prescription, direct to be supplied in a dose of the drug. (2) If only one amount is mentioned in the column of the table in Part 2 of Schedule 1 headed “Maximum Amount” (the maximum amount column) in relation to a chemotherapy drug, that amount is the maximum amount of the chemotherapy drug for all purposes. (3) If more than one amount is mentioned in the maximum amount column in relation to a chemotherapy drug, then: (a) if a purposes code is mentioned in the column of the table headed “Purposes” in relation to an amount—that amount is the maximum amount of the chemotherapy drug for the purposes mentioned in the table in Part 1 of Schedule 3 for that purposes code; and (b) if no purposes code is mentioned in the column in relation to an amount—that amount is the maximum amount for all purposes other than purposes to which paragraph (a) applies. (4) For a chemotherapy drug mentioned in column 1 of an item of the following table: (a) an amount mentioned in the maximum amount column in relation to the chemotherapy drug is the maximum amount, of the active ingredient mentioned in column 2 of the item of the following table, that an authorised prescriber may direct to be supplied in a dose of the chemotherapy drug; and (b) a reference in this instrument to the maximum amount of the chemotherapy drug is taken to be a reference to the maximum amount of the active ingredient.
<table cellspacing="0" cellpadding="0" style="margin-left:0.25pt; border-collapse:collapse"><thead><tr><td colspan="3" style="width:404.8pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Maximum amounts for chemotherapy drugs with multiple active ingredients</span></p></td></tr><tr><td style="width:24.9pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Item</span></p></td><td style="width:179.15pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Column 1</span></p><p class="Tabletext"><span style="font-weight:bold">Chemotherapy drug</span></p></td><td style="width:179.15pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Column 2</span></p><p class="Tabletext"><span style="font-weight:bold">Active ingredient</span></p></td></tr></thead><tbody><tr><td style="width:24.9pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>1</span></p></td><td style="width:179.15pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>daunorubicin with cytarabine</span></p></td><td style="width:179.15pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>daunorubicin</span></p></td></tr><tr><td style="width:24.9pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>2</span></p></td><td style="width:179.15pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>nivolumab with relatlimab</span></p></td><td style="width:179.15pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>nivolumab</span></p></td></tr></tbody></table>